abrdn Healthcare Investors 

$19
198
-$0.13-0.67%过去一周

统计数据

当日最高
19.23
当日最低
19
52周最高
19.79
52周最低
14.31
成交量
96,086
平均成交量
168,950
市值
959.34M
市盈率
14.47
股息收益率
9.67%
股息
1.84

即将到来

股息

9.67%股息收益率
10年增长
-0.84%
5年增长
3.47%
3年增长
-0%
1年增长
27.5%

收益

7Dec预期
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q3 2022
-2.48
-0.21
2.06
4.33
预期每股收益
0
实际每股收益
-1.64

人们还关注

此列表基于关注HQH的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。
abrdn Healthcare Opportunities Fund
THQ
市值0
Tekla Healthcare Opportunities Fund是一家直接竞争对手,专注于类似HQH的医疗保健行业投资。
abrdn Life Sciences Investors
HQL
市值417.92M
Tekla Life Sciences Investors在同一领域运营,直接与HQH竞争,投资于生命科学和医疗保健。
Vanguard Health Care
VHT
市值0
Vanguard Health Care ETF为寻求医疗保健投资的投资者提供广泛的行业覆盖,与HQH竞争。
Health Care Select Sector SPDR
XLV
市值0
Health Care Select Sector SPDR Fund是一家竞争对手,因为它提供类似的医疗保健行业投资机会,追求类似的投资目标。
iShares U.S. Healthcare Providers
IHF
市值0
iShares美国医疗保健提供商ETF通过专注于医疗保健提供商来竞争,这是HQH的一个重要投资领域。
VanEck Biotech
BBH
市值0
VanEck Vectors Biotech ETF通过投资生物技术公司与HQH竞争,生物技术公司是医疗保健行业的重要组成部分。
Invesco Pharmaceuticals
PJP
市值0
Invesco Dynamic Pharmaceuticals ETF是一家竞争对手,专注于制药业,这是医疗保健行业的一个重要领域,HQH也可能会考虑目标。
iShares U.S. Healthcare
IYH
市值0
iShares美国医疗保健ETF通过提供广泛的美国医疗保健股票投资,与HQH的投资重点类似,进行竞争。
Fidelity MSCI Health Care Index
FHLC
市值0
Fidelity MSCI Health Care Index ETF通过跟踪MSCI USA IMI Health Care指数的表现,提供类似的行业曝光,从而竞争。
Blackrock Health Sciences Trust
BME
市值574.54M
BlackRock Health Sciences Trust 是一家竞争对手,专注于健康科学,并与对医疗保健行业投资感兴趣的同一投资者群体竞争。

关于

Miscellaneous
Investment Trusts/Mutual Funds
Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Show more...
首席执行官
国家
US

上市公司